Your browser doesn't support javascript.
loading
Negative impact of immunoparesis in response to anti-SARS-CoV-2 mRNA vaccination of patients with multiple myeloma.
Onishi, Akio; Matsumura-Kimoto, Yayoi; Mizutani, Shinsuke; Isa, Reiko; Fujino, Takahiro; Tsukamoto, Taku; Miyashita, Akihiro; Okumura, Keita; Nishiyama, Daichi; Hirakawa, Koichi; Shimura, Kazuho; Kaneko, Hiroto; Kiyota, Miki; Kawata, Eri; Takahashi, Ryoichi; Kobayashi, Tsutomu; Uchiyama, Hitoji; Uoshima, Nobuhiko; Nukui, Yoko; Shimura, Yuji; Inaba, Tohru; Kuroda, Junya.
Afiliación
  • Onishi A; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan.
  • Matsumura-Kimoto Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan.
  • Mizutani S; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
  • Isa R; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan.
  • Fujino T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan.
  • Tsukamoto T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan.
  • Miyashita A; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan.
  • Okumura K; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan.
  • Nishiyama D; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Hirakawa K; Faculty of Clinical Laboratory, University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Shimura K; Department of Hematology, Fukuchiyama City Hospital, Fukuchiyama, Japan.
  • Kaneko H; Department of Hematology, Fukuchiyama City Hospital, Fukuchiyama, Japan.
  • Kiyota M; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan.
  • Kawata E; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan.
  • Takahashi R; Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan.
  • Kobayashi T; Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan.
  • Uchiyama H; Department of Hematology, Omihachiman Community Medical Center, Omihachiman, Japan.
  • Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Nukui Y; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Shimura Y; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Inaba T; Division of Infection Control & Molecular Laboratory Medicine, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan.
Int J Hematol ; 119(1): 50-61, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38082201
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Mieloma Múltiple Límite: Humans Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Mieloma Múltiple Límite: Humans Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Japón